Try our beta test site
71 studies found for:    vaccine adverse reactions | Open Studies
Hide Display Options

Display Options

Study Details
Participant Details
Identifiers
Dates
Rank Status Study
1 Recruiting VA-008 ACAM2000® Vaccination of Plasma Donors for the Production of VIGIV
Condition: Smallpox Vaccine Adverse Reaction
Intervention: Biological: Vaccination with ACAM2000
2 Not yet recruiting Safety Study of Enterovirus 71 Vaccine in Children Aged 6-35 Months Old
Condition: Enterovirus 71 Vaccine
Intervention: Biological: two doses enterovirus 71 vaccine
3 Recruiting A Phase Ⅳ Clinical Trial of the Recombinant Hepatitis E Vaccine (Escherichia Coli)(Coadministration With Recombinant Hepatitis B Vaccine)
Conditions: Hepatitis E;   Hepatitis B
Interventions: Biological: HEV vaccine;   Biological: HBV vaccine
4 Not yet recruiting Safety and Immunogenicity Study of Human Papilloma Virus Vaccine in Women Aged 9 to 30 and Men Aged 9 to 17
Condition: Cervical Cancer
Interventions: Biological: Tetravalent recombinant human papilloma virus vaccine (6,11,16,18 type) (Hansenula polymorpha);   Biological: placebo
5 Recruiting A Study to Evaluate the Safety and Efficacy of Therapeutic Hepatitis B Vaccine
Condition: Hepatitis B, Chronic
Intervention: Biological: CVI-HBV-002
6 Not yet recruiting Measles-Rubella Vaccine Immunogenicity at 6 and 9 Months of Age
Conditions: Measles;   Rubella;   Rubella Syndrome, Congenital
Interventions: Biological: Measles-rubella (MR) vaccine at 6 and 9 months;   Biological: Measles-rubella (MR) vaccine at 9 months
7 Recruiting Phase III Trial to Evaluate Efficacy and Safety of a Tetravalent Dengue Vaccine
Condition: Dengue
Interventions: Biological: Dengue 1,2,3,4 (attenuated) vaccine;   Other: Placebo
8 Not yet recruiting Safety, Three Batches Consistency and Immunity Duration of the Post-marketing Inactivated Enterovirus Type 71 (EV71) Vaccine in Children Aged 6-71 Months
Condition: Hand Foot and Mouth Disease
Interventions: Biological: the first batch vaccine;   Biological: the second batch vaccine;   Biological: the third batch vaccine
9 Recruiting The National Cancer Institute Opens A Randomized, Double-Blind, Phase 2 Trial of GI-6301 (Yeast-Brachyury Vaccine) Versus Placebo in Combination With Standard of Care Definitive Radiotherapy in Locally Advanced, Unresectable, Chordoma
Condition: Chordoma
Interventions: Other: GI-6301 Placebo;   Biological: GI-6301 Vaccine (Yeast- Brachyury);   Radiation: Radiotherapy
10 Not yet recruiting Immunogenicity and Safety Study of the 13-valent Pneumococcal Polysaccharide Conjugate Vaccine in 2-71 Months Old Healthy Infants and Toddlers (the Youngest Could be 6 Weeks Old)
Condition: Diseases Caused by Streptococcus Pneumoniae Serotypes
Interventions: Biological: 7-valent pneumococcal conjugate vaccine;   Biological: 13-valent pneumococcal polysaccharide conjugate vaccine
11 Recruiting Evaluate Safety of ComBe Five (Liquid) in Healthy Vietnamese Children Aged From 8 - 10 Weeks as a 3-dose Series, Interval for Each Dose is 4 Weeks
Condition: Safety, Pentavalent Vaccine
Intervention: Biological: ComBe Five (Liquid)
12 Recruiting Safety and Tolerability of Herpes Zoster Vaccine Rheumatologic Patients
Condition: Herpes Zoster
Intervention: Biological: Zostavax vaccine
13 Recruiting HBV Vaccine in Renal Failure Patients
Condition: Renal Failure
Interventions: Biological: Intradermal HBVv with imiquimod;   Biological: Intradermal HBVv with aqueous cream;   Biological: Intramuscular HBVv with aqueous cream
14 Not yet recruiting Vaccination Uptake (VAX) in PD
Condition: Parkinson's Disease
Interventions: Behavioral: Standard of Care;   Behavioral: Home Visit Program (HVP)
15 Recruiting VZV Vaccine for Hematopoietic Stem Cell Transplantation
Condition: Varicella Zoster Infection
Interventions: Biological: Zostavax;   Biological: Normal Saline
16 Not yet recruiting P3+ Intervention Phase
Condition: Vaccination
Interventions: Behavioral: Control Site;   Behavioral: Intervention Site;   Behavioral: Patient-level Control Group;   Behavioral: Patient-level Intervention Group
17 Recruiting αDC1 Vaccine + Chemokine Modulatory Regimen (CKM) as Adjuvant Treatment of Peritoneal Surface Malignancies
Conditions: Malignant Neoplasm of Pancreas Metastatic to Peritoneal Surface;   Malignant Peritoneal Mesothelioma;   Peritoneal Carcinomatosis
Interventions: Biological: DC vaccine;   Drug: Celecoxib;   Drug: Interferon Alfa-2b;   Biological: rintatolimod
18 Recruiting A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 6 Months Through 59 Months of Age.
Condition: Influenza, Human
Interventions: Biological: Seqirus Quadrivalent Inactivated Influenza Vaccine;   Biological: Comparator Quadrivalent Inactivated Influenza Vaccine
19 Not yet recruiting Active Surveillance for Adverse Events Following Immunization With the Influenza Vaccine Produced at Butantan Institute
Condition: Influenza Vaccines
Intervention: Biological: Influenza seasonal vaccine
20 Recruiting Phase 3 Study of BK1310 in Healthy Infants
Condition: Immunization; Infection
Interventions: Biological: DPT-IPV-Hib-High (Combined Vaccine);   Biological: DPT-IPV-Hib-Low (Combined Vaccine);   Biological: Hib vaccine;   Biological: DPT-IPV

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.